Trial intelligence / Profile preview

Antithrombin supplementation after cardiac surgery with extracorporeal circulation in patients with low postoperative antithrombin levels

2010-020377-16Phase 4Active

Sponsor
Policlinico di Bari
Start
Sep 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of antithrombin III in Antithrombin deficiency (ATD) and coagulopathy (2 arms), sponsored by Policlinico di Bari. Primary endpoints: Blood loss, Blood transfusions and blood product use and 23 more. Started Sep 2010; status: active.

02

Drugs

antithrombin III
03

Conditions

Antithrombin deficiency (ATD)coagulopathy

Beyond the preview

Go deeper on 2010-020377-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020377-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call